Skip to main content
Christopher Wolfe, MD, Cardiology, Olympia, WA

ChristopherLWolfeMD

Cardiology Olympia, WA

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Pulse Heart Institute

Dr. Wolfe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wolfe's full profile

Already have an account?

  • Office

    406 Black Hills Ln SW
    Ste A
    Olympia, WA 98502
    Phone+1 360-754-1737
    Fax+1 360-704-3408

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1982 - 1985
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 1978 - 1981
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 1978
  • American University of Beirut
    American University of BeirutB.A., Ancient History, With Distinction, 1972 - 1974

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - Present
  • WA State Medical License
    WA State Medical License 1997 - 2025
  • NC State Medical License
    NC State Medical License 1999 - 2000
  • TX State Medical License
    TX State Medical License 1982 - 1997
  • GA State Medical License
    GA State Medical License 1981 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Top 10 Cardiologist, Physician Registry 2013
  • Best Doctors in America 2006
  • America's Top Doctors 2005
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirfofiban and aspirin  
    Blazing MA, de Lemos JA, White HA, et al, JAMA, 1/1/2004
  • Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes  
    de Lemos JA, Blazing MA, Wiviott SD, et al, JAMA, 1/1/2004
  • Effect of statin therapy on C-reactive protein levels  
    Albert MA, Danielson E, Rifai N, Ridker for the PRINCE Investigators, JAMA, 1/1/2001
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Preconditioning ischemia time determines the degree of apoptosis and infarct size reduction in rat hearts in vivo.
    Bui SK, Piot CA, Wolfe CL, J Am Coll Cardiol, 1/1/1999
  • Cost-effectiveness with preservation of diagnostic accuracy among patients presenting to the Emergency Department with chest pain.
    Sciammarella MG, Wolfe CL, Lizotte P, Sirke B, Botvinick E, J Invest Med, 1/1/1998
  • Antiangiogenic action of 16K hRPL involves activation of apoptosis.
    Martini JF, Piot C, Wolfe CL, Weiner RI, Mol Biol Cell, 1/1/1997
  • Join now to see all

Lectures

  • Debate: Heat Shock Proteins Protect the Heart from Ischemic Injury. 
    1/1/1998
  • Heat Shock Proteins and Myocardial Protection from Ischemic Injury. 
    1/1/1997
  • Treatment of Acute Myocardial Infarction. 
    1/1/1991

Professional Memberships